NasdaqGM - Nasdaq Real Time Price USD

Revance Therapeutics, Inc. (RVNC)

Compare
3.6300
-0.0100
(-0.27%)
At close: January 30 at 4:00:00 PM EST
3.6302
+0.00
+(0.01%)
After hours: 7:48:26 PM EST
All numbers in thousands
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
478,454.0000
581,900.0000
531,163.0000
720,220.0000
Total Liabilities Net Minority Interest
630,058.0000
569,300.0000
462,692.0000
345,930.0000
Total Equity Gross Minority Interest
-151,604.0000
12,600.0000
68,471.0000
374,290.0000
Total Capitalization
274,991.0000
391,974.0000
349,106.0000
554,816.0000
Common Stock Equity
-151,604.0000
12,600.0000
68,471.0000
374,290.0000
Capital Lease Obligations
49,339.0000
39,094.0000
43,877.0000
31,583.0000
Net Tangible Assets
-161,412.0000
-99,919.0000
-133,827.0000
155,983.0000
Working Capital
249,641.0000
299,045.0000
178,828.0000
389,039.0000
Invested Capital
277,491.0000
391,974.0000
349,106.0000
554,816.0000
Tangible Book Value
-161,412.0000
-99,919.0000
-133,827.0000
155,983.0000
Total Debt
478,434.0000
418,468.0000
324,512.0000
212,109.0000
Net Debt
291,766.0000
270,409.0000
170,012.0000
--
Share Issued
87,962.7650
82,385.8100
71,584.0570
69,178.6660
Ordinary Shares Number
87,962.7650
82,385.8100
71,584.0570
69,178.6660
12/31/2020 - 2/6/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers